Patents by Inventor Ralph Lindemann

Ralph Lindemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240050563
    Abstract: The present disclosure relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to the combined use of a PD-1 inhibitor, a TGF-beta inhibitor, and a MCT4 inhibitor to treat cancer.
    Type: Application
    Filed: November 1, 2021
    Publication date: February 15, 2024
    Inventors: Ada Sala-Hojman, Frank Czauderna, Ralph Lindemann, Roberta Ferretti, Shivapriya Ramaswamy